Diabetes And Hemodialysis 1 Dr.Ruba Nashawati. 2.

Slides:



Advertisements
Similar presentations
William Vega-Ocasio MD. Internal Medicine - Nephrology
Advertisements

+ Understanding Kidney Disease and Renal Dialysis Brooke Grussing Concordia College.
End Stage Renal Disease in Children. End stage kidney disease occurs when the kidneys are no longer able to function at a level that is necessary for.
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Treatment Options for End Stage Kidney Disease Dr Vipula De Silva.
Renal Replacement Therapy: What the PCP Needs to Know.
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Chapter 71 Care of Patients with Acute Renal Failure and Chronic.
Calcium & phosphor disturbance CKD- MBD Dr. Atapour.
DIABETES AND THE KIDNEYS
National Institute for Health and Clinical Excellence.
DM & CKD Dr. Shahrzad Shahidi Professor of Nephrology Isfahan University of Medical Sciences.
RENAL BLOOD TESTS WHAT DO THEY MEAN, WHERE TO GO FOR WHAT TO DO.
LOGICAL DRUG THERAPY IN CHRONIC KIDNEY DISEASE Dr S.Raeisi Nephrologist, MD.
Chronic Kidney Disease and Diabetes Dr Garth Hanson.
PRINCIPLES OF DIALYSIS DR SAAD ALSHOHAIB ASSOCIATE PROFESSOR IN MEDICINE AND NEPHROLOGY KAUH.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Chronic Kidney Disease
Chronic kidney disease Alternative Names Kidney failure - chronic Renal failure - chronic Chronic renal insufficiency Chronic kidney failure Chronic kidney.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.
Approach to Advanced Kidney Disease Management in the Elderly Source: Schell JO, Germain MJ, Finkelstein FO, et al. An integrative approach to advanced.
RENAL DISEASE IN DIABETES
Diabetic Nephropathy Yiming Lit, M.D. May 5, 2009.
1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.
CHRONIC RENAL FAILURE JAKUB ZÁVADA KLINIKA NEFROLOGIE 1.LF UK.
Diseases of the Renal System KNH 413. CKD - Renal Replacement Therapy Hemodialysis (HD) or Peritoneal Dialysis (PD) Type based on underlying kidney disease.
Microvascular complications Diabetes Outreach (August 2011)
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
CHRONIC RENAL FAILURE R.Manoj Kumar.
Diabetes and Kidney. Diabetic Kidney Normal Kidney.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
ACUTE STROKE — Hypertension is a common problem in patients with both type 1 and type 2 diabetes but the time course in relation to the duration.
CASE 1. Donald is a 68 year-old man who is admitted to hospital via the Emergency Department one day, following a myocardial infarction. Subsequent investigation.
Your next patient is a woman in her mid 30’s. She complains of patient in her lower back, radiating to her right flank and down into the groin. What else.
Peritoneal Dialysis End Stage Renal Disease Causes and Treatment Methods.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Hemodialysis. Hemodialysis (also haemodialysis) is a method for removing waste products such as potassium and urea, as well as free water from the blood.
Diabetic nephropathy. Diabetic nephropathy- definition Chronic microangiopathy type complication of DM characterized by: 1. proteinuria 2. hypertension.
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
J Winterbottom 2005 Chronic Renal Failure Jean Winterbottom Clinical Educator MRI.
Section 5: Configuration of healthcare to manage CKD.
Chronic Kidney Disease: Treatment. Slowing the Progression of CKD Protein Restriction – KDOQI guidelines g/kg per day – Sufficient energy.
Anatomy Management of CKD LECTURE 10 Hazem.Kadhum Al-khafaji MD.FICMS Department of medicine Al-Qadissiah university.
Kidney Disorders By Amir Ashkan Ashrafian M.D.  A spectrum of different pathophysiologic processes associated with abnormal kidney function and a progressive.
CHRONIC KIDNEY DISEASE
Chapter 37 Chronic Kidney Disease: The New Epidemic
Progression of Chronic Kidney Disease
DR. HAYAM HEBAH ASSOCIATE PROFESSOR OF INTERNAL MEDICINE AL MAAREFA COLLEGE DIALYSIS.
Stella Lawal NUR 532 Molloy College Response to the following questions  How many pair of kidney does a person has?  Where are they located?  What.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
Dr.Ruba Nashawati. Diabetes  Leading cause of ESRD  30% 40%  DN  DN Risk type I = type II.
HTN & CKD 1. HTN has been reported to occur in 85-95% of patients with CKD (stages 3–5). The relationship between HTN & CKD is cyclic in nature. Uncontrolled.
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Associate professor of Internal Medicine
BY DR WAQAR MBBS , MRCP ASSISTANT PROFESSOR
2017 Annual Data Report Healthy People 2020.
Diseases of the Renal System
Current and future management of diabetic renal failure
Chronic kidney disease and pre-dialysis
Acute and Chronic Renal Failure
Dialysis Options: What is the Best Choice for You. Ana C
2018 Annual Data Report Volume 3: Healthy People 2020
Section 5: Configuration of healthcare to manage CKD
Meeting the challenges of the new K/DOQI guidelines
Diseases of the Renal System
Diseases of the Renal System
Presentation transcript:

Diabetes And Hemodialysis 1 Dr.Ruba Nashawati

2

DM+CKD Renal Care + Dialysis 3

Type 2 + CKD  Nephrologist ASAP Death is Cardiac ≈ ½ Dead patient Survival DM +HD < Other +HD 4

Renal disease Diabetic Nephropathy Hypertensive Vascular Disease Glomerular Tubulointerstitial 5

Symptoms Of Kidney Disease Fluid retention (Oedema legs/face ) Fatigue Headache Nausea Vomiting BY INCIDENCE BY INCIDENCE 6

Therapeutic goal In Stage 3-5 CKD 1. Treatment of complications 2. Aggressive therapy of coexisting disease (CVD) 3. Correct choice of Renal Replacement Therapy (RRT) 7

Metabolic Control 8

Glucose Control 1. Insulin Resistance  Insulin requirements 2. HD  Insulin requirements 20% 9

Glucose Control Diabetes “CURED” /Advancing CKD 1. Reduced appetite and CHO intake 2. Prolonged insulin half-life 3. False elevation of HbA1c by 0.5-1% 10

Glucose Control Recommend  Insulin Dose50-70% (non-Dialytic) HBA1c % 11

Glucose Control We recommend a target hemoglobin A1c (HbA1c) of B7.0% (53 mmol/mol) to prevent or delay progression of the microvascular complications of diabetes, including diabetic kidney disease. 12

Glucose Control We recommend not treating to an HbA1c target of 7.0% (53 mmol/mol) in patients at risk of hypoglycemia. 13

Glucose Control We suggest that target HbA1c be extended above 7.0% (53mmol/mol) in individuals with comorbidities or limited life expectancy and risk of hypoglycemia. 14

15

Blood pressure Target 130/80 mmHg ACEi /ARBS B-Blocker Loop Diuretics 16

Lipid Control 1 st choice  statin 17

Lipid Control 18 GFR <30Max dose Atorvastatin80mg/dl Fluvastatin80mg/dl Pravastatin10mg/dl Simvastatin20mg/dl Rosovastatin10mg/dl EzitimibeSafe

Diet We suggest lowering protein intake to 0.8 g/kg/day in adults with diabetes or without diabetes and GFR 30 ml/min/ 1.73 m2 (GFR categories G4-G5), with appropriate education 19

Diet We suggest avoiding high protein intake (41.3 g/kg/day) in adults with CKD at risk of progression 20

Anemia Occur Early Sever Usually  Cardiac Death Treat With Erythropoietin Studies  High Doses Than Non Diabetics 21

Minerals And Bone We recommend measuring serum levels of calcium,phosphate, PTH, and alkaline phosphatase activity at least once in adults with GFR 45 ml/min/1.73 m2 22

Minerals And Bone GFR categories (G3b-G5) in order to determine baseline values and inform prediction equations if used. 23

Minerals And Bone In people with GFR 45 ml/min/1.73m2 GFR categories (G3b-G5), we suggest maintaining serum phosphate concentrations in the normal range according to local laboratory reference values. 24

Minerals And Bone In people with GFR 45 ml/min/1.73m2 GFR categories (G3b-G5) the optimal PTH level is not known. 25

Minerals And Bone We suggest that people with levels of intact PTH above the upper normal limit of the assay are first evaluated for hyperphosphatemia, hypocalcaemia, and vitamin D deficiency. 26

27

Renal Replacement Therapy 28

Hemodialysis 29

Peritoneal Dialysis 30

Renal Transplantation 31

Choice of a Dialysis modality Choice of a Dialysis modality modality modality 1. Comorbid conditions 2. Home situation 3. Independence and motivation of the patient. 4. Ability to tolerate volume shifts (hypotensive) 5. Status of the vascular/ abdomen 6. Risk of infection 32

Choice of a Dialysis modality 1. No preference for HD over PD 2. Young Tx is over HD 3. Prepare as early as possible 4. Diabetics will ESRD of all ages benefit from kidney transplantation 5. Type1 =benefit +pancreas transplantation 33

When to start If One or more are present 34

When to start 1. Symptoms or signs of CKD 2. Electrolyte abnormalities/pruritus 3. Inability to control volume status /blood pressure 4. Progressive deterioration in nutritional status; or cognitive impairment Usually GFR Diabetics tolerate less so GFR even 20 35

Vascular Acces Difficult vascular access Frequent sepsis 36

Vascular Acces Arterio-venous (AV) Fistula PTFE Graft Temporary catheters “Permanent” catheters 37

Diabetes and ESKD Reducing insulin requirements Difficult vascular access Accelerated macrovascular disease Advanced microvascular disease Frequent sepsis Silent ischaemia 2-3 x death rate vs non-DM patients 38

39 Temporary Catheters

“Permanent” catheters 40

41 PTFE Graft

42

Non Renal Complication In Diabetics That keep Progression 43

1. Cardiac Arterial Disease 2. Retinopathy 3. Cataract 4. Cerebrovascular Disease 5. Peripheral Vascular Disease 44

1. Autoimmune Neuropathy 2. Peripheral Neuropathy 3. Sexual Dysfunction 4. Depression 45

Problems Due To DM On HD 46

Silent ischaemia  regular consultation Gastroparesis  metoclopramide Blood glucose control Insulin requirements  PD  HD Hypotension ≈ Autonomic neuropathy  UF rate / Hb / Na profile 47

Vascular disease Difficult to get vascular access Steal syndrome Retinopathy Infection  special care for accesses Impotence 48

Q. Which features are typical of diabetic CKD at presentation ? Haematuria NO Small scarred kidneys NO Progress to ESKD in <2yrs NO Associated retinopathy YES  -blockers better than ACE-I Rx NO 49

At The End 50

Although the development and progression of Diabetic Nephropathy may be retarded by normalization HTN (ACEi/ARBs) and strict control of the plasma glucose concentration, many patients still progress to ESRD 51

52